The emerging treatment of the medication represents a exciting development in the care of the condition. Different to existing medications, tirzepatide targets multiple pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide629592.jaiblogs.com/69107893/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment